Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation

Author： Sánchez-Ortega Isabel  

Publisher： Informa Healthcare

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.6, 2013-06, pp. : 736-743

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of antibacterial prophylaxis with non‐absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 647-654

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of antibacterial prophylaxis with non‐absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 5, 2015-10 ,pp. : 647-654

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 134, Iss. 3, 2015-05 ,pp. : 146-154

Karger

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

By  

TRANSFUSION, Vol. 41-1132, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

The efficacy and safety of sirolimus‐based graft‐versus‐host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta‐analysis of randomized controlled trials

By  

TRANSFUSION, Vol. 55, Iss. 9, 2015-09 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite